ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2688

Increased Serum Uric Acid Levels Are Associated with a Higher Risk of Digital Ulcers in Patients with Systemic Sclerosis

Han-Na Lee1, Seung-Geun Lee1, Eunsung Kim1, JungHee Koh1, Yun-Kyung Kim2, Ho-Jae Kim2 and Geun-Tae Kim3, 1Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea, Republic of (South), 3Kosin University College of Medicine, Busan, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: fibrosis, Systemic sclerosis, uric acid and vasculogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Endothelial cell dysfunction and/or injury are considered critical early events in the pathogenesis of vasculopathy in patients with systemic sclerosis (SSc). Hyperuricemia is known to induce endothelial dysfunction and vascular inflammation; however, the link between uric acid and SSc vasculopathy has not been well established. We investigated whether increased serum uric acid levels (SUA) are associated with the digital ulcers (DUs) in patients with SSc.

Methods: In this cross-sectional study, we consecutively recruited 71 women with SSc and 103 age- and sex-matched healthy subjects at a university-affiliated rheumatology center, and SUA levels were measured in all study subjects. All patients with SSc fulfilled the preliminary classification criteria established by the American College of Rheumatology for SSc. Active DUs were defined as a loss of epithelialization and tissues involving the epidermis, dermis, subcutaneous tissue, and bone. DUs included both, active and healed lesions.

Results:

The mean (±standard deviation) SUA levels in patients with SSc were significantly higher than those in controls (4.5±1 vs. 4.2±0.9 mg/dL, respectively, p=0.027). Patients with SSc showed a significantly lower body mass index (BMI) than healthy subjects (21.8±2.8 vs. 23.3±3.5 kg/m2, respectively, p=0.005) whereas no statistically significant intergroup difference was observed in the estimated glomerular filtration rate (eGFR). Among patients with SSc, 22 (31%) had DUs (active DUs: 8, healed DUs: 14). Patients with SSc presenting with DUs showed significantly higher SUA levels than those without DUs (5±1 vs. 4.3±0.9 mg/dL, respectively, p=0.008). In multivariable logistic regression models adjusting for confounders including BMI and eGFR, increased SUA levels were observed to be independently associated with a higher risk for the presence of DUs as shown in Table 1 (OR 2.3, 95% CI 1.16–4.57, p=0.018). Additionally, the modified Rodnan skin score and the disease duration showed a significant association with DUs (OR 1.14, 95% CI 1.03–1.27, p=0.013; and OR 1.01, 95% CI 1–1.02, p=0.023, respectively).

Table 1. Association between serum uric acid level and digital ulcers ever in patients with systemic sclerosis evaluated by logistic regression models

Variables

Univariable model

Multivariable model

Crude OR (95% CI)

p-value

*Adjusted OR (95% CI)

p-value

SUA level, mg/dL

2.19 (1.23-3.92)

0.008

2.3 (1.16-4.57)

0.018

MRSS

1.14 (1.04-1.25)

0.004

1.14 (1.03-1.27)

0.013

Disease duration, months

1.01 (1-1.02)

0.02

1.01 (1-1.02)

0.023

ILD

3.27 (1.1-9.78)

0.034

–

–

eGFR, mL/min/1.73m2

1.01(0.98-1.03)

0.508

–

–

BMI, kg/m2

0.97 (0.81-1.16)

0.72

–

–

PAH

0.51 (0.1-2.6)

0.424

Anti-centromere antibody

0.38 (0.1-1.51)

0.169

Anti-Scl70 antibody

0.65 (0.21-1.95)

0.437

Diffuse SSc (ref. limited SSc)

1.33 (0.49-3.66)

0.576

* Estimated using backward multivariable logistic regression models including SUA levels, MRSS, disease duration, ILD, eGFR and BMI.

Conclusion: Our data revealed that elevated SUA levels are associated with a higher risk for DUs in patients with SSc regardless of confounding factors, thereby suggesting the potential role of hyperuricemia in the pathogenesis of SSc vasculopathy.


Disclosure: H. N. Lee, None; S. G. Lee, None; E. Kim, None; J. Koh, None; Y. K. Kim, None; H. J. Kim, None; G. T. Kim, None.

To cite this abstract in AMA style:

Lee HN, Lee SG, Kim E, Koh J, Kim YK, Kim HJ, Kim GT. Increased Serum Uric Acid Levels Are Associated with a Higher Risk of Digital Ulcers in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-serum-uric-acid-levels-are-associated-with-a-higher-risk-of-digital-ulcers-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-serum-uric-acid-levels-are-associated-with-a-higher-risk-of-digital-ulcers-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology